|
EIF4E expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.70543612354868E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.29896093881143E-13 |
| Normal-vs-Stage2 |
1.3776999999715E-06 |
| Normal-vs-Stage3 |
1.52460000180099E-08 |
| Normal-vs-Stage4 |
7.612500E-04 |
| Stage1-vs-Stage2 |
3.358400E-01 |
| Stage1-vs-Stage3 |
6.784600E-01 |
| Stage1-vs-Stage4 |
1.830440E-01 |
| Stage2-vs-Stage3 |
6.062800E-01 |
| Stage2-vs-Stage4 |
5.999800E-01 |
| Stage3-vs-Stage4 |
3.318800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7590373602161E-12 |
| Normal-vs-AfricanAmerican |
1.42669998037803E-09 |
| Normal-vs-Asian |
8.33940000000144E-05 |
| Caucasian-vs-AfricanAmerican |
2.225400E-01 |
| Caucasian-vs-Asian |
9.853000E-01 |
| AfricanAmerican-vs-Asian |
7.080600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.54040000036149E-07 |
| Male-vs-Female |
9.190100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.42630052002835E-10 |
| Normal-vs-Extreme_Weight |
2.55229171131077E-12 |
| Normal-vs-Obese |
1.96960003862046E-10 |
| Normal-vs-Extreme_Obese |
6.776200E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.853800E-01 |
| Normal_Weight-vs-Obese |
8.052400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.983800E-01 |
| Extreme_Weight-vs-Obese |
2.346800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.641800E-01 |
| Obese-vs-Extreme_Obese |
9.203200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.29939999999429E-05 |
| Normal-vs-Age(41-60Yrs) |
5.20317122720826E-12 |
| Normal-vs-Age(61-80Yrs) |
1.79134485023269E-12 |
| Normal-vs-Age(81-100Yrs) |
1.22769999721939E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.673800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.343000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.167000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.089800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.812400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.198400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.626032641866E-12 |
| Normal-VS-Type2 PRCC |
1.48192569326966E-12 |
| Normal-VS-KIRP CIMP |
5.508200E-02 |
| Normal-VS-Unclassified PRCC |
2.87119994446527E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.288000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.573600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.563600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.828000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.577600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.290990E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.81269999999234E-06 |
| Normal-vs-N2 |
1.944430E-03 |
| N0-vs-N1 |
8.126500E-02 |
| N0-vs-N2 |
4.443200E-01 |
| N1-vs-N2 |
8.037000E-01 |
|
|
